58 results
424B5
CRVS
Corvus Pharmaceuticals Inc
3 May 24
Prospectus supplement for primary offering
4:05pm
) on any gain realized upon the sale or other taxable disposition of the Securities, which may be offset by certain U.S. source capital losses of the non
8-K
EX-99.1
uoir4j9gbjd 8xqc
3 Nov 22
Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2022 Financial Results
4:06pm
8-K
EX-99.1
6r3rfqpmgn6zg wi6ln
2 Aug 21
Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2021 Financial Results
4:10pm
8-K
EX-99.1
i19qsal94fq
29 Apr 21
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2021 Financial Results
4:08pm
DEFA14A
zlz372 iw4a2u
20 Apr 21
Additional proxy soliciting materials
5:02pm